强直性脊柱炎中西医结合诊疗指南

标题: 强直性脊柱炎中西医结合诊疗指南
title: Clinical Guideline of integration of traditional Chinese and Western Medicine for ankylosing spondylitis
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 诊疗
field: Diagnosis and Management
国家和地区: 中国
Country and region: China
指南使用者: 中医或中西医结合的临床医师
Guide users: TCM Clinicians; Clinicians of Integrated Chinese and Western Medicine
证据分级方法:
Evidence grading method: We used the Grading of Recommendations, Assessment,Development and Evaluation (GRADE) method to develop the recommendations.
制定单位: 上海市光华中西医结合医院
Formulating unit: ShangHai GuangHua Hospital of Integrated Traditional Chinese and Western Medicine
注册时间: 2020-10-12
Registration time:
注册编号: IPGRP-2020CN152
Registration number:
指南制订的目的: 目前国际AS诊疗指南的发布主要由美国风湿病学会(American College of Rheumatology,ACR)及欧洲抗风湿病联盟(the European League Against Rheumatism,EULAR)主导。国内西医风湿病指南的修订主要由中华医学会风湿病学会主导,主要针对ACR和EULAR发布的风湿病诊疗指南结合中国病患特点做出修订,使国际诊疗指南更适合中国实际。但自2010年在《中华风湿病学杂志》发布《强直性脊柱炎诊断及治疗指南》后,学会一直未对该指南作更新。而且,近十年来国内外均无强直性脊柱炎的中西医结合诊疗指南,这成为制约强直性脊柱炎规范化诊疗的一大阻碍。风湿科属于较年青的学科,许多来自基层的医生水平参差不齐,他们对强直性脊柱炎的诊治尤其是中医的诊治还处于依赖个人经验的阶段,误诊、漏诊较多,临床疗效难以满意,处于基层的他们亟需提高强直性脊柱炎规范化诊疗水平。 鉴于上述原因,我们按照循证临床实践指南制订的方法和步骤,基于最新的研究证据,结合我国临床实际,制订了本指南。
Purpose of the guideline: At present, the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) dominate the publication of international guidelines of ankylosing spondylitis (AS). These guidelines provide authoritative recommendations for medical staffs around the world and are updated every 2-3 years. In China, the guidelines for diagnosis and treatment of rheumatic diseases are mainly formulated by Chinese Rheumatology Association of Chinese Medical Association. Combined with the characteristics of Chinese patients,the guidelines published by ACR and EULAR was revised by the Chinese Rheumatology Association so as to make the guidelines more in line with the actual situati -on in China. However, the Association had not updated the guideline since the Chinese Journal of Rheumatology published a guideline for the diagnosis and treatment of ankylosing spondylitis in 2010. Moreover, there was no guideline for the diagnosis and treatment of ankylosing spondylitis with integrated traditional Chinese and Western Medicine at home and abroad in recent 10 years, which has become a major obstacle to the standardized diagnosis and treatment of ankylosing spondylitis in China. Finally, Rheumatology is too young for other subjects, and the level of doctors from the grass-roots unit are uneven. Most of them rely personal experiences more than on guidelines to diagnose and treat AS, which lead to many misdiagnosis and the unsatisfied curative effects . It is urgent for us to formulate a guideline to standardize their clinical diagnosis and treatment of AS. To sum up, based on the latest research evidence and the clinical practice in China, we will formulate a guideline in accordance with the authoritative guidelines for developing guidelines,.